Abstract
Background: The term premature pubarche (PP) refers to the appearance of pubic hair before age 8 in girls and before age 9 in boys. Although idiopathic PP (often associated with premature adrenarche) is considered an extreme variation from the norm, it may be an initial sign of persistent hyperandrogenism. Factors contributing to PP onset and progression have not been identified to date. Aims: The objectives of this study are to describe a group of Italian children with PP, to identify potential factors for its onset, and to define its clinical and biochemical progression. Methods: We retrospectively enrolled all infants born between 2001 and 2014 with PP. Children with advanced bone age (BA) underwent functional tests to determine the cause of PP. Hormonal analysis and BA determination were performed annually during a 4-year follow-up period. Results: A total of 334 children with PP were identified: idiopathic PP (92.5%, associated with premature adrenarche in some cases); related to precocious puberty (6.6%); late-onset 21-hydroxylase deficiency (0.9%). Low birth weight was associated with premature adrenal activation. Body mass index (BMI) was the only factor that influenced the progression of BA during follow-up. Conclusions: Low birth weight is a predisposing factor for premature adrenal activation. The increase in BMI in patients with idiopathic PP during the 4-years of follow-up was responsible for BA acceleration. We recommend prevention of excessive weight gain in children with PP and strict adherence to follow-up in order to prevent serious metabolic consequences.
References
1.
Diaz
A
, Bhandari
S
, Sison
C
, Vogiatzi
M
. Characteristics of children with premature pubarche in the New York metropolitan area
. Horm Res
. 2008
;70
(3
):150
–4
. .2.
Silverman
SH
, Migeon
C
, Rosemberg
E
, Wilkins
L
. Precocious growth of sexual hair without other secondary sexual development; premature pubarche, a constitutional variation of adolescence
. Pediatrics
. 1952
;10
(4
):426
–32
.3.
Ibáñez
L
, Dimartino-Nardi
J
, Potau
N
, Saenger
P
. Premature adrenarche: normal variant or forerunner of adult disease?
Endocr Rev
. 2000
;21
(6
):671
–96
. .4.
Oberfield
SE
, Sopher
AB
, Gerken
AT
. Approach to the girl with early onset of pubic hair
. J Clin Endocrinol Metab
. 2011
;96
(6
):1610
–22
. .5.
Ghizzoni
L
, Gasco
V
. Premature pubarche
. Horm Res Paediatr
. 2010
;73
(5
):420
–2
. .6.
Saenger
P
, Reiter
EO
. Premature adrenarche: a normal variant of puberty?
J Clin Endocrinol Metab
. 1992
;74
(2
):236
–8
. .7.
Voutilainen
R
, Jääskeläinen
J
. Premature adrenarche: etiology, clinical findings, and consequences
. J Steroid Biochem Mol Biol
. 2015
;145
:226
–36
. .8.
Idkowiak
J
, Lavery
GG
, Dhir
V
, Barrett
TG
, Stewart
PM
, Krone
N
, et al Premature adrenarche: novel lessons from early onset androgen excess
. Eur J Endocrinol
. 2011
;165
(2
):189
–207
. .9.
Williams
RM
, Ward
CE
, Hughes
IA
. Premature adrenarche
. Arch Dis Child
. 2012
;97
(3
):250
–4
. .10.
Baulieu
EE
, Corpechot
C
, Dray
F
, Emiliozzi
R
, Lebeau
MC
, Mauvais Jarvis
P
, et al An adrenal-secreted “Androgen”: dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man
. Recent Progr Horm Res
. 1965
;21
:411
–500
.11.
Kelnar
CJ
, Brook
CG
. A mixed longitudinal study of adrenal steroid excretion in childhood and the mechanism of adrenarche
. Clin Endocrinol
. 1983
;19
(1
):117
–29
. .12.
Utriainen
P
, Laakso
S
, Liimatta
J
, Jääskeläinen
J
, Voutilainen
R
. Premature adrenarche: a common condition with variable presentation
. Horm Res Paediatr
. 2015
;83
(4
):221
–31
. .13.
Sopher
AB
, Jean
AM
, Zwany
SK
, Winston
DM
, Pomeranz
CB
, Bell
JJ
, et al Bone age advancement in prepubertal children with obesity and premature adrenarche: possible potentiating factors
. Obesity
. 2011
;19
(6
):1259
–64
. .14.
Remer
T
, Manz
F
, Hartmann
MF
, Schoenau
E
, Wudy
SA
. Prepubertal healthy children’s urinary androstenediol predicts diaphyseal bone strength in late puberty
. J Clin Endocrinol Metab
. 2009
;94
(2
):575
–8
. .15.
Rosenfield
RL
. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited
. Horm Res
. 1994
;41
(Suppl 2
):7
–13
. .16.
Cavarzere
P
, Mauro
M
, Vincenzi
M
, Lauriola
S
, Teofoli
F
, Gaudino
R
, et al Children with premature pubarche: is an alterated neonatal 17-OHP screening test a predictive factor?
Ital J Pediatr
. 2018
;44
(1
):10
. .17.
Cacciari
E
, Milani
S
, Balsamo
A
, Spada
E
, Bona
G
, Cavallo
L
, et al Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)
. J Endocrinol Invest
. 2006
;29
(7
):581
–93
. .18.
Tanner
JM
, Whitehouse
RH
. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty
. Arch Dis Child
. 1976
;51
(3
):170
–9
. .19.
Tanner
JM
, Goldstein
H
, Whitehouse
RH
. Standards for children’s height at ages 2-9 years allowing for heights of parents
. Arch Dis Child
. 1970
;45
(244
):755
–62
. .20.
Bertino
E
, Spada
E
, Occhi
L
, Coscia
A
, Giuliani
F
, Gagliardi
L
, et al Neonatal anthropometric charts: the Italian neonatal study compared with other European studies
. J Pediatr Gastroenterol Nutr
. 2010
;51
(3
):353
–61
. .21.
Clayton
PE
, Cianfarani
S
, Czernichow
P
, Johannsson
G
, Rapaport
R
, Rogol
A
. Management of the child born small for gestational age through to adulthood: a consensus statement of the International societies of pediatric endocrinology and the growth hormone research society
. J Clin Endocrinol Metab
. 2007
;92
(3
):804
–10
. .22.
Greulich
WW
, Pyle
SI
. Radiographic atlas of skeletal development of the hand and wrist
. 2nd ed. Stanford
: Stanford University Press
; 1959
.23.
New
MI
, Lorenzen
F
, Lerner
AJ
, Kohn
B
, Oberfield
SE
, Pollack
MS
, et al Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
. J Clin Endocrinol Metab
. 1983
;57
(2
):320
–6
. .24.
Armengaud
JB
, Charkaluk
ML
, Trivin
C
, Tardy
V
, Bréart
G
, Brauner
R
, et al Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche
. J Clin Endocrinol Metab
. 2009
;94
(8
):2835
–40
. .25.
Ghanny
BA
, Malhotra
S
, Kumta
S
, Kazachkova
I
, Homel
P
, Jacobson-Dickman
E
, et al Should children with isolated premature adrenarche be routinely evaluated for non-classical congenital adrenal hyperplasia?
J Pediatr Endocrinol Metab
. 2016
;29
(3
):351
–6
. .26.
Ibáñez
L
, Bonnin
MR
, Zampolli
M
, Prat
N
, Alia
PJ
, Navarro
MA
. Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche
. Horm Res
. 1995
;44
(2
):51
–6
. .27.
Leite
MV
, Mendonça
BB
, Arnhold
IJ
, Estefan
V
, Nunes
C
, Nicolau
W
, et al Identification of nonclassical 21-hydroxylase deficiency in girls with precocious pubarche
. J Endocrinol Invest
. 1991
;14
(1
):11
–5
. .28.
Speiser
PW
, Dupont
B
, Rubinstein
P
, Piazza
A
, Kastelan
A
, New
MI
. High frequency of nonclassical steroid 21-hydroxylase deficiency
. Am J Hum Genet
. 1985
;37
(4
):650
–67
.29.
Skordis
N
, Shammas
C
, Phedonos
AA
, Kyriakou
A
, Toumba
M
, Neocleous
V
, et al Genetic defects of the CYP21A2 gene in girls with premature adrenarche
. J Endocrinol Invest
. 2015
;38
(5
):535
–9
. .30.
Neocleous
V
, Shammas
C
, Phedonos
AP
, Karaoli
E
, Kyriakou
A
, Toumba
M
, et al Genetic defects in the cyp21a2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia
. Georgian Med News
. 2012
;210
(210
):40
–7
.31.
Knochenhauer
ES
, Cortet-Rudelli
C
, Cunnigham
RD
, Conway-Myers
BA
, Dewailly
D
, Azziz
R
. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism
. J Clin Endocrinol Metab
. 1997
;82
(2
):479
–85
. .32.
Escobar-Morreale
HF
, San Millán
JL
, Smith
RR
, Sancho
J
, Witchel
SF
. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations
. Fertil Steril
. 1999
;72
(4
):629
–38
. .33.
Admoni
O
, Israel
S
, Lavi
I
, Gur
M
, Tenenbaum-Rakover
Y
. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype
. Clin Endocrinol
. 2006
;64
(6
):645
–51
. .34.
Witchel
SF
, Lee
PA
, Suda-Hartman
M
, Hoffman
EP
. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency
. Biochem Mol Med
. 1997
;62
(2
):151
–8
. .35.
Carel
JC
, Léger
J
. Clinical practice. Precocious puberty
. N Engl J Med
. 2008
;358
(22
):2366
–77
. .36.
Carel
JC
, Eugster
EA
, Rogol
A
, Ghizzoni
L
, Palmert
MR
; ESPE-LWPES GnRH Analogs Consensus Conference Group
, et al Consensus statement on the use of gonadotropin-releasing hormone analogs in children
. Pediatrics
. 2009
;123
:e752
–62
.37.
Brito
VN
, Batista
MC
, Borges
MF
, Latronico
AC
, Kohek
MB
, Thirone
AC
, et al Diagnostic value of fluorometric assays in the evaluation of precocious puberty
. J Clin Endocrinol Metab
. 1999
;84
(10
):3539
–44
. .38.
Ding
Y
, Li
J
, Yu
Y
, Yang
P
, Li
H
, Shen
Y
, et al Evaluation of basal sex hormone levels for activation of the hypothalamic-pituitary-gonadal axis
. J Clin Endocrinol Metab
. 2018
;31
(3
):323
–9
. .39.
Pasternak
Y
, Friger
M
, Loewenthal
N
, Haim
A
, Hershkovitz
E
. The utility of basal serum LH in prediction of central precocious puberty in girls
. Eur J Endocrinol
. 2012
;166
(2
):295
–9
. .40.
Ong
KK
, Potau
N
, Petry
CJ
, Jones
R
, Ness
AR
, Honour
JW
, et al Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls
. J Clin Endocrinol Metab
. 2004
;89
(6
):2647
–51
. .41.
Barker
DJ
, Winter
PD
, Osmond
C
, Margetts
B
, Simmonds
SJ
. Weight in infancy and death from ischaemic heart disease
. Lancet
. 1989
;2
(8663
):577
–80
. .42.
Paterson
WF
, Ahmed
SF
, Bath
L
, Donaldson
MD
, Fleming
R
, Greene
SA
, et al Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistry
. Clin Endocrinol
. 2010
;72
(4
):496
–501
. .43.
Utriainen
P
, Jääskeläinen
J
, Romppanen
J
, Voutilainen
R
. Childhood metabolic syndrome and its components in premature adrenarche
. J Clin Endocrinol Metab
. 2007
;92
(11
):4282
–5
. .44.
Meas
T
, Chevenne
D
, Thibaud
E
, Léger
J
, Cabrol
S
, Czernichow
P
, et al Endocrine consequences of premature pubarche in post-pubertal Caucasian girls
. Clin Endocrinol
. 2002
;57
(1
):101
–6
. .45.
Santos-Silva
R
, Costa
C
, Castro-Correia
C
, Fontoura
M
. Clinical, biochemical and gender characteristics of 97 prepubertal children with premature adrenarche
. J Pediatr Endocrinol Metab
. 2019
;32
(11
):1247
–52
. .46.
Charkaluk
ML
, Trivin
C
, Brauner
R
. Premature pubarche as an indicator of how body weight influences the onset of adrenarche
. Eur J Pediatr
. 2004
;163
(2
):89
–93
. .47.
Ghirri
P
, Bernardini
M
, Vuerich
M
, Cuttano
AM
, Coccoli
L
, Merusi
I
, et al Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls
. Gynecol Endocrinol
. 2001
;15
(2
):91
–7
. .48.
Neville
KA
, Walker
JL
. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity
. Arch Dis Child
. 2005
;90
(3
):258
–61
. .49.
Ibáñez
L
, Potau
N
, Francois
I
, De Zegher
F
. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth
. J Clin Endocrinol Metab
. 1998
;83
(10
):3558
–62
. .50.
Vuguin
P
, Linder
B
, Rosenfeld
RG
, Saenger
P
, DiMartino-Nardi
J
. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche
. J Clin Endocrinol Metab
. 1999
;84
(6
):2037
–42
. .51.
Reinehr
T
, De Sousa
G
, Roth
CL
, Andler
W
. Androgens before and after weight loss in obese children
. J Clin Endocrinol Metab
. 2005
;90
(10
):5588
–95
. .52.
Kaya
G
, Yavas Abali
Z
, Bas
F
, Poyrazoglu
S
, Darendeliler
F
. Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty
. Eur J Pediatr
. 2018
;177
(11
):1593
–601
. .53.
Burt Solorzano
CM
, McCartney
CR
. Obesity and the pubertal transition in girls and boys
. Reproduction
. 2010
;140
(3
):399
–410
. .54.
Shalitin
S
, Phillip
M
. Role of obesity and leptin in the pubertal process and pubertal growth: a review
. Int J Obes Relat Metab Disord
. 2003
;27
(8
):869
–74
. .55.
Matkovic
V
, Ilich
JZ
, Skugor
M
, Badenhop
NE
, Goel
P
, Clairmont
A
, et al Leptin is inversely related to age at menarche in human females
. J Clin Endocrinol Metab
. 1997
;82
(10
):3239
–45
. .56.
Saenger
P
, Dimartino-Nardi
J
. Premature adrenarche
. J Endocrinol Invest
. 2001
;24
(9
):724
–33
. .57.
Shalitin
S
, Kiess
W
. Putative effects of obesity on linear growth and puberty
. Horm Res Paediatr
. 2017
;88
(1
):101
–10
. .58.
Marcovecchio
ML
, Chiarelli
F
. Obesity and growth during childhood and puberty
. World Rev Nutr Diet
. 2013
;106
:135
–41
. .59.
Grumbach
MM
. Estrogen, bone, growth and sex: a sea change in conventional wisdom
. J Pediatr Endocrinol Metab
. 2000
;13
(Suppl 6
):1439
–55
. .60.
De Groot
CJ
, Van den Berg
A
, Ballieux
BEPB
, Kroon
HM
, Rings
EHHM
, Wit
JM
, et al Determinants of advanced bone age in childhood obesity
. Horm Res Paediatr
. 2017
;87
(4
):254
–63
. .61.
Liimatta
J
, Utriainen
P
, Voutilainen
R
, Jääskeläinen
J
. Trajectories of growth and serum DHEAS and IGF-1 concentrations in girls with a history of premature adrenarche: attenuation of the phenotype by adulthood
. Front Endocrinol
. 2018
;9
:375
. .62.
Oron
T
, Lebenthal
Y
, de Vries
L
, Yackobovitch-Gavan
M
, Phillip
M
, Lazar
L
. Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome
. J Pediatr
. 2012
;160
(2
):308
–13
. .© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
